Mark P. Colonnese
2017 - Biota Pharmaceuticals
In 2017, Mark P. Colonnese earned a total compensation of $608K as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Option Awards | $226,754 |
|---|---|
| Salary | $349,800 |
| Other | $31,442 |
| Total | $607,996 |
Colonnese received $349.8K in salary, accounting for 58% of the total pay in 2017.
Colonnese also received $226.8K in option awards and $31.4K in other compensation.
Rankings
In 2017, Mark P. Colonnese's compensation ranked 11,140th out of 14,666 executives tracked by ExecPay. In other words, Colonnese earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,140 out of 14,666 | 24th |
Division Manufacturing | 4,353 out of 5,770 | 25th |
Major group Chemicals And Allied Products | 1,577 out of 2,074 | 24th |
Industry group Drugs | 1,297 out of 1,730 | 25th |
Industry Biological Products, Except Diagnostic Substances | 233 out of 316 | 26th |
Source: SEC filing on February 26, 2018.
Colonnese's colleagues
We found one more compensation record of an executive who worked with Mark P. Colonnese at Biota Pharmaceuticals in 2017.
2017
Joseph Patti
Biota Pharmaceuticals